Similarly, Apelin-13 has demonstrated the ability to combat neuroinflammation associated with AD by lowering IL-1β and TNF-α levels and promoting brain-derived neurotrophic factor/tropomyosin-related kinase B receptor (BDNF/TrkB) signaling. Here, BDNF is linked to Alzheimer disease.